Gibson Dunn Deal Wins 2020 Healthcare, Pharma & Biotech Deal of the Year

Accolades  |  July 31, 2020

The Deal


The Deal Awards Middle Market named Merck & Co.’s acquisition of Immune Design Corp. its 2020 Healthcare, Pharma & Biotech Deal of the Year. Gibson Dunn was legal advisor to Merck in the transaction.  The recognition was announced July 31, 2020.

Gibson Dunn’s Mergers and Acquisitions Practice Group is an international leader in mergers, acquisitions, divestitures, spin-offs, proxy contests and joint ventures.  Our M&A clients include public and private companies, ranging from Fortune 100 and multinational corporations to smaller companies; private equity firms; boards of directors and special committees; selling shareholders; management teams; and financial advisors.